Nicolas Daniel Glasbauer , Silvia Sookoian , Carlos José Pirola
{"title":"Identifying molecular pathways of olfactory dysfunction in Parkinson’s disease through a systems biology framework","authors":"Nicolas Daniel Glasbauer , Silvia Sookoian , Carlos José Pirola","doi":"10.1016/j.neuroscience.2025.05.031","DOIUrl":null,"url":null,"abstract":"<div><div>The sense of smell is essential for human perception. Olfactory function declines with increasing age, affecting a substantial portion of the elderly population, and this decline is more pronounced in men. This reduction can be attributed to anatomical and degenerative changes in the brain and olfactory receptors. There is robust clinical evidence indicating an association between olfactory perception decline/deficit (OPD) and major neurodegenerative diseases, with severe deficits observed in Alzheimer’s and Parkinson’s disease and milder effects noted in other conditions. However, its molecular bases have not yet been identified.</div><div>Here, we explored the molecular connection between OPD and Parkinson’s disease by conducting data-mining, gene enrichment analysis, and examining protein-interaction networks using systems biology approaches.</div><div>We found pathways associated with both OPD and Parkinson’s disease, identifying over 300 relevant genes. These genes belong to biologically relevant gene families, including transporters, kinases, nuclear receptors, transcription factors, and olfactory and other G protein-coupled receptors. Functional enrichment analysis revealed shared biological processes between OPD and Parkinson’s disease, such as synaptic signalling and neuroinflammation. Mitochondrial gene enrichment was unique to Parkinson’s. Both conditions exhibited a scarcity of associated genes on the Y chromosome but an even distribution on the non-pseudoautosomal region of the X chromosome, potentially explaining sex prevalence differences.</div><div>In conclusion, our study suggests olfactory testing may help diagnose cognitive decline in neurodegenerative diseases. Further research is needed to understand the connection between OPD, aging, and other diseases and to examine olfactory performance in screening individuals at risk of Parkinson’s disease and similar conditions.</div></div>","PeriodicalId":19142,"journal":{"name":"Neuroscience","volume":"577 ","pages":"Pages 264-271"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306452225003938","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The sense of smell is essential for human perception. Olfactory function declines with increasing age, affecting a substantial portion of the elderly population, and this decline is more pronounced in men. This reduction can be attributed to anatomical and degenerative changes in the brain and olfactory receptors. There is robust clinical evidence indicating an association between olfactory perception decline/deficit (OPD) and major neurodegenerative diseases, with severe deficits observed in Alzheimer’s and Parkinson’s disease and milder effects noted in other conditions. However, its molecular bases have not yet been identified.
Here, we explored the molecular connection between OPD and Parkinson’s disease by conducting data-mining, gene enrichment analysis, and examining protein-interaction networks using systems biology approaches.
We found pathways associated with both OPD and Parkinson’s disease, identifying over 300 relevant genes. These genes belong to biologically relevant gene families, including transporters, kinases, nuclear receptors, transcription factors, and olfactory and other G protein-coupled receptors. Functional enrichment analysis revealed shared biological processes between OPD and Parkinson’s disease, such as synaptic signalling and neuroinflammation. Mitochondrial gene enrichment was unique to Parkinson’s. Both conditions exhibited a scarcity of associated genes on the Y chromosome but an even distribution on the non-pseudoautosomal region of the X chromosome, potentially explaining sex prevalence differences.
In conclusion, our study suggests olfactory testing may help diagnose cognitive decline in neurodegenerative diseases. Further research is needed to understand the connection between OPD, aging, and other diseases and to examine olfactory performance in screening individuals at risk of Parkinson’s disease and similar conditions.
嗅觉对人类的知觉是必不可少的。嗅觉功能随着年龄的增长而下降,影响了相当一部分老年人,这种下降在男性中更为明显。这种减少可归因于大脑和嗅觉受体的解剖和退行性变化。有强有力的临床证据表明嗅觉感知下降/缺陷(OPD)与主要神经退行性疾病之间存在关联,在阿尔茨海默病和帕金森病中观察到严重的缺陷,而在其他疾病中观察到轻微的影响。然而,其分子基础尚未被确定。在这里,我们通过数据挖掘、基因富集分析和使用系统生物学方法检查蛋白质相互作用网络来探索OPD与帕金森病之间的分子联系。我们发现了与OPD和帕金森病相关的途径,确定了300多个相关基因。这些基因属于生物学上相关的基因家族,包括转运蛋白、激酶、核受体、转录因子、嗅觉和其他G蛋白偶联受体。功能富集分析揭示了OPD和帕金森病之间共享的生物学过程,如突触信号传导和神经炎症。线粒体基因富集是帕金森病特有的。这两种情况都表现出Y染色体上相关基因的稀缺,但在 X 染色体的非假常染色体区域上分布均匀,这可能解释了性别患病率的差异。总之,我们的研究表明嗅觉测试可能有助于诊断神经退行性疾病的认知能力下降。需要进一步的研究来了解OPD、衰老和其他疾病之间的联系,并检查嗅觉表现在筛查帕金森病和类似疾病风险个体中的作用。
期刊介绍:
Neuroscience publishes papers describing the results of original research on any aspect of the scientific study of the nervous system. Any paper, however short, will be considered for publication provided that it reports significant, new and carefully confirmed findings with full experimental details.